Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian D Hay

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
World Journal of Surgery|October 15, 2017
Papillary Thyroid Carcinoma (PTC) in Children and Adults: Comparison of Initial Presentation and Long-Term Postoperative Outcome in 4432 Patients Consecutively Treated at the Mayo Clinic During Eight Decades (1936-2015)Ian D Hay, Tammi R Johnson, Suneetha Kaggal, et al.
Archives of Surgery (Chicago, Ill. : 1960)|May 17, 2006
Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancerJohn M Stulak, Clive S Grant, David R Farley, et al.
Surgery|December 2, 2008
Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year periodIan D Hay, Maeve E Hutchinson, Tomas Gonzalez-Losada, et al.
Clinical Endocrinology|August 11, 2017
FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significanceBryan McIver, Stefan K G Grebe, Liang Wang, et al.
Thyroid : Official Journal of the American Thyroid Association|July 18, 2008
18F-FDG PET in the management of patients with anaplastic thyroid carcinomaTrond Velde Bogsrud, Dimitrios Karantanis, Mark A Nathan, et al.
Molecular Imaging and Biology|December 2, 2009
The prognostic value of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in patients with suspected residual or recurrent medullary thyroid carcinomaTrond Velde Bogsrud, Dimitrios Karantanis, Mark A Nathan, et al.
Journal of the Endocrine Society|October 19, 2020
Long-Term Results of Treating With Ethanol Ablation 15 Adult Patients With cT1aN0 Papillary Thyroid MicrocarcinomaIan D Hay, Robert A Lee, Suneetha Kaggal, et al.
Nuclear Medicine Communications|February 1, 2011
Prognostic value of 18F-fluorodeoxyglucose-positron emission tomography in patients with differentiated thyroid carcinoma and circulating antithyroglobulin autoantibodiesTrond Velde Bogsrud, Ian D Hay, Dimitrios Karantanis, et al.
Nuclear Medicine Communications|April 7, 2007
The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CTTrond V Bogsrud, Dimitrios Karantanis, Mark A Nathan, et al.
The Journal of Clinical Endocrinology and Metabolism|October 16, 2004
PPARgamma staining as a surrogate for PAX8/PPARgamma fusion oncogene expression in follicular neoplasms: clinicopathological correlation and histopathological diagnostic valueMustafa Sahin, Brandon L Allard, Martin Yates, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
World Journal of Surgery|October 15, 2017
Papillary Thyroid Carcinoma (PTC) in Children and Adults: Comparison of Initial Presentation and Long-Term Postoperative Outcome in 4432 Patients Consecutively Treated at the Mayo Clinic During Eight Decades (1936-2015)Ian D Hay, Tammi R Johnson, Suneetha Kaggal, et al.
Archives of Surgery (Chicago, Ill. : 1960)|May 17, 2006
Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancerJohn M Stulak, Clive S Grant, David R Farley, et al.
Surgery|December 2, 2008
Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year periodIan D Hay, Maeve E Hutchinson, Tomas Gonzalez-Losada, et al.
Clinical Endocrinology|August 11, 2017
FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significanceBryan McIver, Stefan K G Grebe, Liang Wang, et al.
Thyroid : Official Journal of the American Thyroid Association|July 18, 2008
18F-FDG PET in the management of patients with anaplastic thyroid carcinomaTrond Velde Bogsrud, Dimitrios Karantanis, Mark A Nathan, et al.
Molecular Imaging and Biology|December 2, 2009
The prognostic value of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in patients with suspected residual or recurrent medullary thyroid carcinomaTrond Velde Bogsrud, Dimitrios Karantanis, Mark A Nathan, et al.
Journal of the Endocrine Society|October 19, 2020
Long-Term Results of Treating With Ethanol Ablation 15 Adult Patients With cT1aN0 Papillary Thyroid MicrocarcinomaIan D Hay, Robert A Lee, Suneetha Kaggal, et al.
Nuclear Medicine Communications|February 1, 2011
Prognostic value of 18F-fluorodeoxyglucose-positron emission tomography in patients with differentiated thyroid carcinoma and circulating antithyroglobulin autoantibodiesTrond Velde Bogsrud, Ian D Hay, Dimitrios Karantanis, et al.
Nuclear Medicine Communications|April 7, 2007
The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CTTrond V Bogsrud, Dimitrios Karantanis, Mark A Nathan, et al.
The Journal of Clinical Endocrinology and Metabolism|October 16, 2004
PPARgamma staining as a surrogate for PAX8/PPARgamma fusion oncogene expression in follicular neoplasms: clinicopathological correlation and histopathological diagnostic valueMustafa Sahin, Brandon L Allard, Martin Yates, et al.
Pageof 6